Human immunodeficiency virus (HIV)

22 596 1
Human immunodeficiency virus (HIV)

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

Thông tin tài liệu

Human Immunodeficiency Virus (HIV) Andrew Borst Isabel VanDerslice Image: http://www.npr.org/blogs/pictureshow/2011/02/22/133868260/sciviz A World Pandemic  HIV has enormous social, economic and humanitarian implications  HIV and AIDS is decimating populations, taxing health infrastructures, and crippling economies, and creating unsustainable population age distributions  Some parts of Africa have a prevalence rate of 1 in 3. For many, infection is inevitable, and treatment beyond reach.  From its discovery in 1981 to 2006, AIDS killed more than 25 million people. The Spread of HIV  Spread through sexual contact, intravenous drug use (infected blood), and mother-to-child during birthing and nursing.  Birthing transmittance rate is 15-30% for mothers infected with HIV.  To minimize risk, antiretroviral therapy is recommend prior to (for the mother) and after birth (for the baby).  Does not spread through mucous membranes, only blood contact.  HIV is a fragile virus Tip of the Day: Use condoms and clean needles! HIV-1 and HIV-2  HIV-1  Binds to CCR5 co-receptor  Most common strain of the Human Immunodeficiency Virus  What most professionals refer to when they reference HIV  HIV-2  Binds to CXCR4 co-receptor  Uncommon; mostly found in Western Africa or individuals of whom are in the later phases of disease progression. Higher HIV-2 prevalence-rates here Vaccine and Treatment  It is difficult to make a vaccine for HIV due to several characteristics of the virus  HAART: Highly active a nti- retroviral therapy is the only effective treatment, but resistance occurs, especially after many years of treatment.  Gene therapy appears to be a good candidate for future HIV treatment options. Vaccine and Treatment Anti-retroviral therapy has significantly reduced the death toll associated with AIDS.  It is difficult to make a vaccine for HIV due to several characteristics of the virus  HAART: Highly active a nti- retroviral therapy is the only effective treatment, but resistance occurs, especially after many years of treatment.  Gene therapy appears to be a good candidate for future HIV treatment options. Human hematopoietic stem/progenitor cells Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to modified by zinc-finger nucleases targeted to CCR5 controls HIV-1 CCR5 controls HIV-1 in vivo in vivo Nathalia Holt, Jianbin Wang, Kenneth Kim, Geoffrey Friedman, Xingchao Wang, Vanessa Taupin, Gay M Crooks, Donald B Kohn, Philip D Gregory, Michael C Holmes & Paula M Cannon HIV-1 Infection  Transmembrane proteins on the surface of the virus interact with receptors on the host cell  Two interactions are needed for entry— CD4-gp120 and a chemokine coreceptor, usually CCR5.  The main reservoirs for HIV in the body are wherever immune cells reside, such as the spleen and intestine. HIV is also found in the follicular dendritic cell (FDC) network.  In tonsils and adenoids of HIV-infected patients, infected macrophages fuse into multinucleated giant cells that produce huge amounts of virus. HIV Infection Mechanism Co-receptor CCR5 Permits HIV-1 Entry • CCR5 is the major co-receptor used by HIV-1 and is expressed on key T-cell subsets and monocytes. • CCR5Δ32 is a relatively common allele in Western Europe • Confers an innate resistance to HIV-1 infection • CCR5 antagonists have proved to be an effective salvage therapy in patients infected with drug-resistant HIV-1 Kuby Immunology says CCR5 is only expressed on Monocytes, but this is an extremely misleading oversimplification. [...]... Normal CD4+ T-cells b) Ratio of human CD4+ to CD8+ lymphocytes in peripheral blood of individual mice to which were infected with HIV-1   Measured pre-infection and 6-8 weeks post-infection Significant reduction in CD4+/CD8+ Tcell ratio in post-infection untreated mice Effects of HIV-1 infection on human cells in HSPCengrafted NSG mice Figure 3 Analysis  a) FACS analysis of human cells in tissues of... unmodified cells  Holds true for both the location of cells and their frequency in that particular tissue Protection of human CD4+ T cells in peripheral blood of HIV-infected mice previously engrafted with ZFN-modified CD34+ HSPCs Figure 2 Analysis  a) FASC readouts showing human CD4+ and CD8+ T-cells in peripheral blood of representative animals from each of three cohorts     Uninfected: Normal... 24 hours after nucleofection     b) Mean percentage of human CD45+ cells in peripheral blood of mice 8 weeks after transplantation   Neg: No gene digestion Mock: No gene digestion ZFN: Gene digestion No statistical difference between Neg, Mock, and ZFN groups c) Fluorescence-activated cell sorting (FACS, or flow cytometry) profiles of human cells of various organs from one ZFN-treated mouse ... infection Spleen: Reduction of CD4+ Thelper cells post HIV-1 infection w/o ZFN treatment Thymus: Complete loss of CD4+ and CD8+ T-cells Small intestine: Complete loss of all human lymphocytes w/o ZFN treatment b) Immunohistochemical analysis of human CD3 expression in small intestine, and CD4 expression in spleen of representative mice Reasons for CD4+ and CD8+ T-cell Depletion in the Thymus  Proposed to... with uninfected ZFN-treated cohorts   c) Contour FACS analysis of human CD4+ T-cells in small intestine and spleen of one representative animal from each cohort   Gel shows increased levels of digestion products in infected mice indicating increased CCR5-/- cell selection Expected results were expected d) Mean +- s.d numbers of human CD4+ cells and CD4+CCR5+ per 5,000 cells analyzed from different... development   Immune hyperactivation underlies much of the pathology of AIDS Not observed in patients unless virus was present prior to treatment Could be used as a backup therapy, or done in addition to HAART My science is perfect A quick word about using proper grammar    “PCR reaction” = BAD “HIV virus = The WORST “Isabel and I’s paper” = The reason for this slide Now…any questions? ... domain Preferentially cleaves DNA at distorted duplexes caused by mismatches  Used for quantification of the CCR5 disrupted alleles NSD Mice:  NOD SCID IFγ-null Mice  Non-obese diabetic severe combined immunodeficiency interferon-gamma null mice    Lack T, B, and NK cells Deficient in multiple cytokine signaling pathways Defects in innate immunity Fun Fact: “Cel” in Cel 1 nuclease stands for celery! . Human Immunodeficiency Virus (HIV) Andrew Borst Isabel VanDerslice Image: http://www.npr.org/blogs/pictureshow/2011/02/22/133868260/sciviz A. fragile virus Tip of the Day: Use condoms and clean needles! HIV-1 and HIV-2  HIV-1  Binds to CCR5 co-receptor  Most common strain of the Human Immunodeficiency

Ngày đăng: 15/03/2014, 12:57

Từ khóa liên quan

Mục lục

  • Human Immunodeficiency Virus (HIV)

  • A World Pandemic

  • The Spread of HIV

  • HIV-1 and HIV-2

  • Vaccine and Treatment

  • Slide 6

  • Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 controls HIV-1 in vivo

  • HIV-1 Infection

  • HIV Infection Mechanism

  • Co-receptor CCR5 Permits HIV-1 Entry

  • ZFN-mediated disruption of CCR5 in CD34+ HSPCs.

  • Slide 12

  • Protection of human CD4+ T cells in peripheral blood of HIV-infected mice previously engrafted with ZFN-modified CD34+ HSPCs.

  • Effects of HIV-1 infection on human cells in HSPC-engrafted NSG mice.

  • Reasons for CD4+ and CD8+ T-cell Depletion in the Thymus

  • HIV-1 infection selects for disrupted CCR5 alleles.

  • ZFN activity produces heterogeneous mutations in CCR5.

  • Control of HIV-1 replication in mice receiving ZFN -treated CD34+ HSPCs

  • Slide 19

  • Conclusions

Tài liệu cùng người dùng

  • Đang cập nhật ...

Tài liệu liên quan